Conference Coverage

Photoprotection strategies for melasma are increasing


 

AT AAD 22

Novel filters

Another emerging option is sunscreen with new filters that cover UVA-1 and visible light. In a randomized, controlled trial of 19 patients, researchers evaluated the addition of methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE) absorber, a new UVA-1 filter known as Mexoryl 400, which has a peak absorption of 385 nm, to a sunscreen formulation.

“Currently, peak absorption in the U.S. is with avobenzone, which peaks at about 357 nm,” but MCE “covers a longer spectrum of UVA-1,” Dr. Lim said. The researchers found that the addition of MCE reduced UVA-1-induced dermal and epidermal alterations at cellular, biochemical, and molecular levels; and decreased UVA-1-induced pigmentation.

Another relatively new filter, phenylene bis-diphenyltriazine (also known as TriAsorB) not only protects against UVA but it extends into the blue light portion of visible light, according to a recently published paper. According to a press release from Pierre Fabre, which has developed the filter, studies have shown that TriAsorB is not toxic for three key species of marine biodiversity: a coral species, a phytoplankton species, and a zooplankton.

This filter and MCE are available in Europe but not in the United States.

Dr. Lim reported that he is an investigator for Incyte, L’Oréal, Pfizer, and the Patient-Centered Outcomes Research Institute.

Pages

Recommended Reading

Practical tips help quell pseudofolliculitis barbae
MDedge Internal Medicine
MRSA incidence decreased in children as clindamycin resistance increased
MDedge Internal Medicine
Vitiligo linked to moles, tanning ability, blistering sunburn
MDedge Internal Medicine
Acne-associated hyperpigmentation an important consideration in patients with skin of color
MDedge Internal Medicine
Know the best specific signs for polycystic ovary syndrome
MDedge Internal Medicine
Bidirectional relationship found between depression, vitiligo
MDedge Internal Medicine
Firing patients
MDedge Internal Medicine
Whether diet, vitamins, or supplements can benefit patients with vitiligo remains unclear
MDedge Internal Medicine
Insurance coverage for vitiligo varies widely in the U.S., analysis finds
MDedge Internal Medicine
Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trial
MDedge Internal Medicine